Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 6
1969 2
1970 9
1971 16
1972 14
1973 16
1974 23
1975 14
1976 12
1977 12
1978 21
1979 12
1980 17
1981 17
1982 14
1983 13
1984 12
1985 11
1986 17
1987 18
1988 16
1989 28
1990 29
1991 20
1992 18
1993 29
1994 40
1995 32
1996 34
1997 52
1998 53
1999 47
2000 61
2001 73
2002 88
2003 100
2004 122
2005 157
2006 177
2007 197
2008 216
2009 239
2010 243
2011 265
2012 288
2013 285
2014 247
2015 289
2016 295
2017 312
2018 286
2019 144
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

4,211 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacokinetic evaluation of a transdermal anastrozole-in-adhesive formulation
Regenthal R, et al. Drug Des Devel Ther 2018. PMID 30464397 Free PMC article.
In vivo data showed a favorable anastrozole plasma concentration-time course, avoiding side effect-associated peak concentrations as obtained after oral administration but matching therapeutic plasma levels up to 72 h. ...
In vivo data showed a favorable anastrozole plasma concentration-time course, avoiding side effect-associated peak concentrations as obtaine …
Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment
Desai A, et al. Antimicrob Agents Chemother 2016 - Clinical Trial. PMID 26953193 Free PMC article.
Food and Drug Administration and the European Medicines Agency for the treatment of adults with invasive aspergillosis and mucormycosis. ...After administration of the single dose, safety data for subjects with mild and moderate hepatic impairment were generally comparable to those for healthy subjects in both studies. ...
Food and Drug Administration and the European Medicines Agency for the treatment of adults with invasive aspergillosis and mucormycos …
4,211 results
Jump to page
Feedback